External Quality Assessment and the Laboratory Diagnosis of Thrombophilia

ABSTRACT

External quality assessment is a tool to compare the result of a particular laboratory test in relation to those of other laboratories as well as to assess the performance of a laboratory test over a prolonged period of time. We evaluated the relationship between the between-laboratory variation and the sample category (normal, borderline, and abnormal) for antithrombin, protein C, protein S, and the activated protein C resistance test. Only for antithrombin and protein S was a significant relationship (0.004 < p < 0.012) observed. The effect of the between-laboratory variation of the different sample categories on the clinical interpretation was investigated. With the exception of free protein S antigen, all variables showed a significant relationship (0.004 < p < 0.045) between the sample category and the percentage of misclassification. Because in clinical practice a stable test performance over a prolonged period of time is important, we evaluated the quality of test performance using the long-term analytical coefficient of variation (LCV_a). A wide range in the LCV_a was observed for antithrombin, protein C, and protein S. Less than half of the participants could fulfill the quality specification for diagnostic testing (LCV_a ≤ 0.58 × total biological variation). This study shows that a more stable performance of laboratory tests involved in the screening of thrombophilia over a prolonged period of time is necessary.

Between-laboratory variation - clinical interpretation - long-term analytical performance

REFERENCES

• 1 Tripodi A. Laboratory diagnosis of thrombophilic states: where do we stand?.  Pathophysiol Haemost Thromb. 2002;  32 245-248
• 2 Michiels J J, Hamulyák K. Laboratory diagnosis of hereditary thrombophilia.  Semin Thromb Hemost. 1998;  24 309-320
• 3 Ehrmeyer S S, Laessig R H. Alternative statistical approach to evaluating interlaboratory performance.  Clin Chem. 1985;  31 106-108
• 4 Fraser C G, Hyltoft Petersen P. Desirable standards for laboratory tests if they are to fulfil medical needs.  Clin Chem. 1993;  39 1447-1455
• 5 Doumas B T. The evaluation and limitations of accuracy and precision standards.  Clin Chim Acta. 1997;  260 145-162
• 6 Thompson S G, Duckert F, Haverkate F, Thomson J M. The measurement of haemostatic factors in 16 European laboratories. Quality assessment for the multicentre ECAT Angina Pectoris Study.  Thromb Haemost. 1989;  61 301-306
• 7 Meijer P, Kluft C, Haverkate F, De Maat M PM. The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation.  J Thromb Haemost. 2003;  1 748-753
• 8 Meijer P, De Maat M P M, Kluft C, Haverkate F, Van Houwelingen H C. Assessment of the long-term analytical performance of field methods in haemostasis by evaluation of results of an external quality assessment programme.  Clin Chem. 2002;  48 1011-1015
• 9 Gowans E M S, Hyltoft Petersen P, Blaabjerg O, Hørder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area.  Scand J Clin Lab Invest. 1988;  48 757-764
• 10 Chambles L E, McMahon R, Wu K K, Folson A, Finch A, Shen Y. Short-term intra-individual variability in haemostasis factors. The ARIC study.  Ann Epidemiol. 1992;  2 723-733
• 11 Nguyen N D, Ghaddar H, Stinson V, Chambless L E, Wu K K. ARIC Hemostasis Study-IV. Intra-individual variability and reliability of hemostatic factors.  Thromb Haemost. 1995;  73 256-260
• 12 Blombäck M, Eneroth P, Landgren B M, Lagerström M, Anderson O. On the intraindividual and gender variability of haemostatic components.  Thromb Haemost. 1992;  67 70-75